INDIAN EQUITY BENCHMARK gained for the fifth straight
session to end at five-week highs led by TCS, Tata Motors and
pharma shares. The government will announce GDP figures for
the December 2013 quarter later today.
Further, Dr. Reddy’s Laboratories ended up 2.4%, extending its
previous day’s 2% gain, after the company said it has launched
Sumatriptan Injection USP in the US.
The government has approved 10 % stake sale in Indian Oil
Corporation to state run ONGC and OIL at a discount of 10 %,
which will fetch about Rs 5,300 crore to the exchequer.
Asian stock markets were lower with the Nikkei also down in
thin trading despite robust economic data coming from Japan.
European stocks mixed to higher as investors were eyeing the
release of highly anticipated euro zone inflation data later in the
U.S. stocks markets climbed higher after Federal Reserve Chair
Janet Yellen suggested harsh winter weather may have been the
reason behind a string of disappointing economic indicators
Arvind gains on JV with a Japanese
Arvind rose 0.97% to Rs 155.85 after the company announced a
joint venture with Goodhill Corporation of Japan by setting up a
Greenfield suits manufacturing facility based out of
Bommansandra Industrial estate in Bengaluru. Arvind's
consolidated net profit surged 35.6% to Rs 102.17 crore on 28%
growth in net sales to Rs 1792.20 crore in Q3 December 2013
over Q3 December 2012.